Skip to main content

and
  1. Article

    Bosutinib-induced lung injury: a report of two cases and literature review

    The prognosis of patients with chronic myeloid leukemia (CML) has improved dramatically since the development of tyrosine kinase inhibitors (TKIs). Three second-generation TKIs, including bosutinib, are curren...

    Naoki Watanabe, Tomoiku Takaku, Yutaka Tsukune in International Journal of Hematology (2022)

  2. Article

    Open Access

    Pulmonary infection due to fluoroquinolone-resistant Mycolicibacterium fortuitum: a case report

    Mycolicibacterium fortuitum is a species of the rapidly growing mycobacteria that can cause pulmonary infection. It is susceptible to multiple antibiotics both in vitro and in clinical practice, so that any combi...

    Kana Kurokawa, Norihiro Harada, Hitoshi Sasano, Haruhi Takagi in BMC Infectious Diseases (2020)

  3. Article

    Open Access

    Anaphylaxis to three humanized antibodies for severe asthma: a case study

    Omalizumab, mepolizumab, benralizumab, and dupilumab are the currently available biologics used to treat asthma in Japan. Anaphylaxis following treatment with mepolizumab or benralizumab is considered rare.

    Koichi **go, Norihiro Harada, Toshihiko Nishioki in Allergy, Asthma & Clinical Immunology (2020)

  4. Article

    Open Access

    Benign giant mediastinal schwannoma presenting as cardiac tamponade in a woman: a case report

    Mediastinal schwannomas are typically benign and asymptomatic, and generally present no immediate risks. We encountered a rare case of a giant benign posterior mediastinal schwannoma, complicated by life-threa...

    Motoyasu Kato, Satomi Shiota, Kazuo Shiga, Haruhi Takagi in Journal of Medical Case Reports (2011)